Resources

ZTS – Market expectations are for recovering Uniform ROA, but management’s concerns about revenue growth imply this may be unwarranted

October 6, 2017

  • Zoetis Inc. (ZTS:USA) currently trades near historical averages relative to UAFRS-based (Uniform) Earnings, at a 26.6x Uniform P/E. At these levels, the market has bullish expectations for the firm, which may be unwarranted given management’s concerns about revenue growth
  • Specifically, management appears concerned about the sustainability of U.S. livestock sales growth, SRS vaccine revenue growth, and growth in their total dermatology portfolio. Should the firm fail to drive Uniform Turns back to historical peaks, as management sentiment suggests, equity downside would be warranted

You don’t have access to the Valens Research Premium Application.

To get access to our best content including the highly regarded Conviction Long List and Market Phase Cycle macro newsletter, please contact our Client Relations Team at 630-841-0683 or email client.relations@valens-research.com.

Please fill out the fields below so that our client relations team can contact you

Or contact our Client Relationship Team at 630-841-0683